Full Development. (1) That the A.O. may either require the drilling and production of such xxxxx as, in his opinion, are necessary to insure reasonable diligence in the development and operation of the property, or in lieu thereof require the payment of an amount as determined by the A.O. to compensate the Lessor in full each month for the estimated loss of royalty.
Full Development. After a well capable of producing Oil or Gas has been completed on the Premises, Lessee will exercise the diligence of a reasonably prudent operator in drilling such additional well or xxxxx as may be reasonably necessary to fully develop the Premises. No payments or fees set forth in the terms of this Lease will relieve Lessee from the obligation to fully develop the Premises. Additionally, Lessee must, upon reasonable request from a lessee of adjoining lands, pool with the lessee of the adjoining lands to achieve secondary or advanced recovery of Oil, Gas, and other hydrocarbons that might be produced through the use of enhanced methods covering a greater area than the Premises.
Full Development. Ligand and/or WYETH from time to time shall make recommendations of those Research Compounds that have completed Exploratory Development for Full Development by WYETH. WYETH shall have the right in its sole discretion, but without the obligation, to select Research Compounds for Full Development and shall give prompt notice to Ligand of each such selection. WYETH shall use its good faith efforts to conduct such preclinical and human clinical trials as WYETH determines are necessary or desirable to obtain regulatory approvals to manufacture and market such Products in the Territory as WYETH desires and diligently to develop, seek necessary approval to market, commence marketing and market such Products for such purpose in the Territory subject to the last sentence of this Section 5.2. WYETH, at its sole expense, shall fund the costs of Full Development of Research Compounds and Products. Notwithstanding anything else in this Amended and Restated Agreement, but subject to Ligand's rights under Section 6.4, WYETH shall have the sole discretion to determine which Products to develop or market, or to continue to develop or market, those for which regulatory approval to market will be sought, and when and where and how and on what terms and conditions, to market such Products in the Territory.
Full Development. TAP, at its sole expense, shall fund the costs of Full Development of Clinical Candidates and Licensed Products. Notwithstanding anything else in this Agreement, but subject to LIGAND's rights under Article 6, TAP shall have the sole discretion to determine which Clinical Candidates and/or Licensed Products to develop or market, or to continue to develop or market, those for which regulatory approval to market will be sought, and when and where and how and on what terms and conditions, to market such Licensed Products in the Territory. LIGAND shall within a reasonable period of time transfer all relevant technical information relating to a particular Clinical Candidate in Full Development by TAP to TAP prior to the initiation by TAP of Phase II studies with respect to such Clinical Candidate; provided LIGAND shall have no obligation to transfer to TAP any LIGAND Information (as defined in Section 11.2 below) related to LIGAND's proprietary technologies or processes not licensed hereunder.
Full Development. LIGAND, SB and/or the LRC from time to time shall make recommendations of those RESEARCH COMPOUNDS that have completed EXPLORATORY DEVELOPMENT for FULL DEVELOPMENT by SB. SB shall have the right in its sole discretion, but without the obligation, to select RESEARCH COMPOUNDS for FULL DEVELOPMENT alone or with others and shall give prompt notice to LIGAND of each such selection. SB shall use its commercially reasonable efforts to conduct such preclinical and human clinical trials as SB determines are necessary or desirable to obtain regulatory approvals to manufacture and market such PRODUCTS in the TERRITORY as SB desires and diligently to develop, seek necessary approval to market, commence marketing and market such PRODUCTS for such purpose in the TERRITORY subject to the last sentence of this Section 5.2. SB, at its sole expense, shall fund the costs of FULL DEVELOPMENT of RESEARCH COMPOUNDS and PRODUCTS. Notwithstanding anything else in this Agreement, but subject to LIGAND's rights under Section 6.2, SB shall have the sole discretion to determine which PRODUCTS to develop or market, or to continue to develop or market, those for which regulatory approval to market will be sought, and when and where and how and on what terms and conditions, to market such PRODUCTS in the TERRITORY. LIGAND may undertake FULL DEVELOPMENT at its own expense, but only under the terms and conditions as provided by ARTICLE 6 herein. Throughout this Agreement, the terms "diligent," "diligently," "diligence," "good faith efforts" and "commercially reasonable efforts" with regard to an SB obligation to develop and/or commercialize a PRODUCT means that SB will exercise its reasonable efforts and diligence in accordance with SB's business, legal, medical and scientific judgment and SB's normal practices and procedures for compounds having similar technical and commercial potential.
